Dr. Glasscock has been at Winthrop since 2000. She went to graduate school at the University of North Carolina-Chapel Hill, where she earned a Ph.D. in experimental and laboratory pathology and investigated the role of serine protease inhibitors in hemostasis and prostate cancer. She then worked at Cannon Research Center of Carolinas Medical Center in Charlotte, N.C., as a post-doctoral fellow and now remains the assistant director of Urology Research there. She teaches "Immunology," "Mechanisms of Disease," "Scientific Process in Biology," "Freshmen Symposium in Biology," "Recent Advances in Cellular and Molecular Biology," and other courses in the department.
Glasscock's research focuses on the role of proteases and their receptors in prostate cancer progression. She is specifically interested in how these proteins regulate the ability of prostate tumor cells to invade and metastasize and also how they regulate the process of angiogenesis. She has received funding for this work from the McKay Urology Endowment fund, the Hemby Foundation, the Freedland Foundation, and other sources. Glasscock was one of a six investigators on Winthrop’s National Institutes of Health South Carolina IDeA Networks of Biomedical Research Excellence (SC INBRE) grant from 2005-2010. This NIH grant supplied faculty, undergraduate, and graduate support for her research. At present Glasscock is one of three Scientific Leadership Co-Project Investigators on Winthrop’s second INBRE grant that was funded in the fall of 2011. She has mentored multiple undergraduate and graduate student research projects. Glasscock also is the faculty advisor for the Department of Biology’s Beta Beta Beta National Biological Honor Society chapter.